Travis E Grotz1, Richard W Joseph2, Barbara A Pockaj3, Robert L Foote4, Clark C Otley5, Sanjay P Bagaria6, Amy L Weaver7, James W Jakub8. 1. Department of Surgery, Mayo Clinic Rochester, Rochester, MN, USA. 2. Department of Medical Oncology, Mayo Clinic Jacksonville, Jacksonville, FL, USA. 3. Department of Surgery, Mayo Clinic Scottsdale, Scottsdale, AZ, USA. 4. Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, USA. 5. Department of Dermatology, Mayo Clinic Rochester, Rochester, MN, USA. 6. Department of Surgery, Mayo Clinic Jacksonville, Jacksonville, FL, USA. 7. Department of Health Sciences Research, Mayo Clinic Rochester, Rochester, MN, USA. 8. Department of Surgery, Mayo Clinic Rochester, Rochester, MN, USA. jakub.james@mayo.edu.
Abstract
BACKGROUND: Controversy exists regarding the predictive ability of a negative sentinel lymph node biopsy (SLNB) and the use of adjuvant radiation in Merkel cell carcinoma (MCC). METHODS: Retrospective study of patients with MCC undergoing SLNB at Mayo Clinic from 1995 to 2011. Cumulative incidence (CI) of regional recurrence and death from MCC, respectively, were estimated taking into account the competing risk of death from other causes and compared between groups using Gray's test. RESULTS: A total of 111 (74 %) of 150 SLNB were negative and comprised our study group. There were 15 regional recurrences, and the CI of a regional recurrence was 5.1, 15.0, and 16.6 % at 1, 3, and 5 years, respectively, after initial surgery. Nine patients (8 % of all patients) experienced a same nodal basin recurrence after a negative SLNB. Among 14 patients who received nodal radiation, the CI of a regional recurrence was 0 and 9.1 % at 1 and 3 years, respectively, compared to 5.8 and 15.5 %, respectively, among the 97 who did not receive nodal radiation (p = 0.45). Male sex was the only characteristic predictive of regional recurrence after a negative SLNB; the CI at 3 years was 21.3 versus 0 % in men and women, respectively (p = 0.007). Head and neck location was not associated with a higher risk of recurrence or an improvement in regional recurrences after radiation. CONCLUSIONS: Same nodal basin recurrences are uncommon after SLNB in MCC, and regional nodal irradiation can be avoided in the setting of successful sentinel lymph node mapping and a negative SLNB.
BACKGROUND: Controversy exists regarding the predictive ability of a negative sentinel lymph node biopsy (SLNB) and the use of adjuvant radiation in Merkel cell carcinoma (MCC). METHODS: Retrospective study of patients with MCC undergoing SLNB at Mayo Clinic from 1995 to 2011. Cumulative incidence (CI) of regional recurrence and death from MCC, respectively, were estimated taking into account the competing risk of death from other causes and compared between groups using Gray's test. RESULTS: A total of 111 (74 %) of 150 SLNB were negative and comprised our study group. There were 15 regional recurrences, and the CI of a regional recurrence was 5.1, 15.0, and 16.6 % at 1, 3, and 5 years, respectively, after initial surgery. Nine patients (8 % of all patients) experienced a same nodal basin recurrence after a negative SLNB. Among 14 patients who received nodal radiation, the CI of a regional recurrence was 0 and 9.1 % at 1 and 3 years, respectively, compared to 5.8 and 15.5 %, respectively, among the 97 who did not receive nodal radiation (p = 0.45). Male sex was the only characteristic predictive of regional recurrence after a negative SLNB; the CI at 3 years was 21.3 versus 0 % in men and women, respectively (p = 0.007). Head and neck location was not associated with a higher risk of recurrence or an improvement in regional recurrences after radiation. CONCLUSIONS: Same nodal basin recurrences are uncommon after SLNB in MCC, and regional nodal irradiation can be avoided in the setting of successful sentinel lymph node mapping and a negative SLNB.
Authors: Richard J Straker; Michael J Carr; Andrew J Sinnamon; Adrienne B Shannon; James Sun; Karenia Landa; Kirsten M Baecher; Christian Wood; Kevin Lynch; Harrison G Bartels; Robyn Panchaud; Michael C Lowe; Craig L Slingluff; Mark J Jameson; Kenneth Tsai; Mark B Faries; Georgia M Beasley; Vernon Sondak; Giorgos C Karakousis; Jonathan S Zager; John T Miura Journal: Ann Surg Oncol Date: 2021-04-22 Impact factor: 5.344
Authors: Francesca Spada; Paolo Bossi; Corrado Caracò; Vanna Chiarion Sileni; Angelo Paolo Dei Tos; Nicola Fazio; Giovanni Grignani; Michele Maio; Pietro Quaglino; Paola Queirolo; Paolo Antonio Ascierto Journal: J Immunother Cancer Date: 2022-06 Impact factor: 12.469
Authors: Jennifer S Ko; Victor G Prieto; Paul J Elson; Ricardo E Vilain; Melissa P Pulitzer; Richard A Scolyer; Jordan P Reynolds; Melissa P Piliang; Marc S Ernstoff; Brian R Gastman; Steven D Billings Journal: Mod Pathol Date: 2015-11-06 Impact factor: 7.842
Authors: Christopher K Bichakjian; Thomas Olencki; Sumaira Z Aasi; Murad Alam; James S Andersen; Rachel Blitzblau; Glen M Bowen; Carlo M Contreras; Gregory A Daniels; Roy Decker; Jeffrey M Farma; Kris Fisher; Brian Gastman; Karthik Ghosh; Roy C Grekin; Kenneth Grossman; Alan L Ho; Karl D Lewis; Manisha Loss; Daniel D Lydiatt; Jane Messina; Kishwer S Nehal; Paul Nghiem; Igor Puzanov; Chrysalyne D Schmults; Ashok R Shaha; Valencia Thomas; Yaohui G Xu; John A Zic; Karin G Hoffmann; Anita M Engh Journal: J Natl Compr Canc Netw Date: 2018-06 Impact factor: 12.693
Authors: Seesha R Takagishi; Tessa E Marx; Christopher Lewis; Erica S Tarabadkar; Ilsa D Juhlin; Astrid Blom; Jayasri G Iyer; Jay J Liao; Yolanda D Tseng; Teresa Fu; Paul Nghiem; Upendra Parvathaneni Journal: Adv Radiat Oncol Date: 2016-10-20
Authors: Tessnim R Ahmad; Harish N Vasudevan; Ann A Lazar; Jason W Chan; Jonathan R George; Michael D Alvarado; Siegrid S Yu; Adil Daud; Sue S Yom Journal: Adv Radiat Oncol Date: 2021-07-31
Authors: Urs Dietmar Achim Müller-Richter; Anja Gesierich; Alexander Christian Kübler; Stefan Hartmann; Roman Camillus Brands Journal: Ann Surg Oncol Date: 2017-07-31 Impact factor: 5.344
Authors: Elena Dellambra; Maria Luigia Carbone; Francesca Ricci; Francesco Ricci; Francesca Romana Di Pietro; Gaia Moretta; Sofia Verkoskaia; Elisa Feudi; Cristina M Failla; Damiano Abeni; Luca Fania Journal: Biomedicines Date: 2021-06-23